GLP-1 and SGLT-2: Treatments Too Good to Ignore? Dr. Peter Nash reviews several studies presented on GLP-1s at #ACR25. He recommends for review abstracts: 0841, 0849, 1027, 2685, 0165, 0233 and 2658. https://t.co/OclO05bpku https://t.co/kASID9jnAP